[gnso-gac-closed-generics] [Ext] Re: Closed Generics Scheduling Update

Mon Mar 13 22:19:50 UTC 2023

Hi Melissa,

I am happy to meet, understanding that we will not be taking decisions in the meeting. Wednesday 8-9am would be preferable for me, but I can also do Thursday 8-9am.

Sophie Hey
she/her
Policy Advisor
Com Laude
T +44 (0) 20 7421 8250
Ext 252

[cid:image002.png at 01D955CF.F788CFF0]<https://comlaude.com/>
From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org> On Behalf Of Melissa Peters Allgood
Sent: Monday, March 13, 2023 5:09 PM
To: Jeff Neuman <jeff at jjnsolutions.com>; John McElwaine <john.mcelwaine at nelsonmullins.com>; Nigel Hickson <nigel.hickson at dcms.gov.uk>
Cc: gnso-gac-closed-generics at icann.org
Subject: Re: [gnso-gac-closed-generics] [Ext] Re: Closed Generics Scheduling Update

Hello again,

This email is a pivot from my previous one. Please forgive me for any whiplash I may cause.

In an attempt to be responsive to the needs of all, I have a compromise to offer regarding an additional meeting of the Closed Generics group during ICANN76.

Staff has secured a meeting room in the Cancun Center on Wednesday  8 - 9 am or Thursday from 8 – 9 am. If you elect to meet, you’d do so with the understanding that decisions will not be taken. This is an opportunity for conversations to continue while ensuring no disadvantage for those who are unable to attend.

If you would like to meet, please respond with your preference, Wednesday 8 -9 am or Thursday 8 -9 am.

Thanks,
Melissa

From: Jeff Neuman <jeff at jjnsolutions.com<mailto:jeff at jjnsolutions.com>>
Date: Monday, March 13, 2023 at 4:13 PM
To: John McElwaine <john.mcelwaine at nelsonmullins.com<mailto:john.mcelwaine at nelsonmullins.com>>, Nigel Hickson <nigel.hickson at dcms.gov.uk<mailto:nigel.hickson at dcms.gov.uk>>, Melissa Peters Allgood <melissa.allgood at icann.org<mailto:melissa.allgood at icann.org>>
Cc: "gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>" <gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>>
Subject: [Ext] Re: [gnso-gac-closed-generics] Closed Generics Scheduling Update

All,

Due to a family emergency, I am leaving Cancun tonight.  I will try and catch up if you do meet or there are other discussions. Sorry to leave on such short notice, but I have to be home now.

Best regards,

Jeffrey J Neuman
JJN Solutions, LLC
Founder & CEO
(202) 549-5079
Jeff at jjnsolutions.com<mailto:Jeff at jjnsolutions.com>
________________________________
From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org<mailto:gnso-gac-closed-generics-bounces at icann.org>> on behalf of John McElwaine <john.mcelwaine at nelsonmullins.com<mailto:john.mcelwaine at nelsonmullins.com>>
Sent: Monday, March 13, 2023 2:28:33 PM
To: Nigel Hickson <nigel.hickson at dcms.gov.uk<mailto:nigel.hickson at dcms.gov.uk>>; Melissa Peters Allgood <melissa.allgood at icann.org<mailto:melissa.allgood at icann.org>>
Cc: gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org> <gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>>
Subject: Re: [gnso-gac-closed-generics] Closed Generics Scheduling Update

Agreed.

From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org<mailto:gnso-gac-closed-generics-bounces at icann.org>> On Behalf Of Nigel Hickson via gnso-gac-closed-generics
Sent: Monday, March 13, 2023 2:20 PM
To: Melissa Peters Allgood <melissa.allgood at icann.org<mailto:melissa.allgood at icann.org>>
Cc: gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>
Subject: Re: [gnso-gac-closed-generics] Closed Generics Scheduling Update

◄External Email► - From: gnso-gac-closed-generics-bounces at icann.org<mailto:gnso-gac-closed-generics-bounces at icann.org>

Melissa cc as above

Good afternoon; in light of the important discussion we had on Saturday; was hoping we may have opportunity to meet before the end of ICANN76; would an early morning not work?

best

Nigel

On Mon, 13 Mar 2023 at 19:11, Melissa Peters Allgood <melissa.allgood at icann.org<mailto:melissa.allgood at icann.org>> wrote:

Hello all,

There was some interest in attempting another hybrid meeting while many of you are in Cancun. Unfortunately, we can’t make it work with your very busy schedules. Please continue to engage with one another and review the Discussion Document – Preliminary Framework for Closed Generic gTLDs v2.<https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__docs.google.com_document_d_1wtLVcyWhyrCaYl1iqlAncaIyrqpS-2D-2D0aPCTjpwMue7I_edit%26d%3DDwMFaQ%26c%3Dqmi9WrYRGQEDDOxOwKrAjW7mWovpzN_EKyRbeK_zbP0%26r%3DKepk-9GEB6JgOj0vUGl8c0hdrRM7FW-8Is-VAQU1VAm5U0rBXiZs3BfB3GfKU2uR%26m%3Do73kKku6Nol5HltVsjUZUZ4XJPUiUADbqudJrCeY5YdIxtDN07tTqDz62lao4hEG%26s%3Dpw_y5VFUwNhc2HZ4gibrDxJY21mT2W30AiTuBvDw6t4%26e%3D&data=05%7C01%7Csophie.hey%40comlaude.com%7Cc90ddb5da5414633734a08db240f9d57%7C442149eed2004029b9b18f029e916b85%7C0%7C0%7C638143421722366612%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=WZfnMF1FT3RwdxMb%2BuV%2BJn47M%2FQ7PgNr2fUbWbGFGsA%3D&reserved=0>

Terri will be in touch regarding our upcoming meeting schedule.

Thanks,

Melissa

_______________________________________________
gnso-gac-closed-generics mailing list
gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>
https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics<https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__mm.icann.org_mailman_listinfo_gnso-2Dgac-2Dclosed-2Dgenerics%26d%3DDwMFaQ%26c%3Dqmi9WrYRGQEDDOxOwKrAjW7mWovpzN_EKyRbeK_zbP0%26r%3DKepk-9GEB6JgOj0vUGl8c0hdrRM7FW-8Is-VAQU1VAm5U0rBXiZs3BfB3GfKU2uR%26m%3Do73kKku6Nol5HltVsjUZUZ4XJPUiUADbqudJrCeY5YdIxtDN07tTqDz62lao4hEG%26s%3DapnDiD8usyjoS2MpfvIzXCI7aNj7-m8RlvjiMn0GNmw%26e%3D&data=05%7C01%7Csophie.hey%40comlaude.com%7Cc90ddb5da5414633734a08db240f9d57%7C442149eed2004029b9b18f029e916b85%7C0%7C0%7C638143421722366612%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=rMm9x6otcM7%2BwWHUIU3jTbyPCU0XZHWE7ktizU%2Fsix4%3D&reserved=0>

_______________________________________________
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (https://www.icann.org/privacy/policy<https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__www.icann.org_privacy_policy%26d%3DDwMFaQ%26c%3Dqmi9WrYRGQEDDOxOwKrAjW7mWovpzN_EKyRbeK_zbP0%26r%3DKepk-9GEB6JgOj0vUGl8c0hdrRM7FW-8Is-VAQU1VAm5U0rBXiZs3BfB3GfKU2uR%26m%3Do73kKku6Nol5HltVsjUZUZ4XJPUiUADbqudJrCeY5YdIxtDN07tTqDz62lao4hEG%26s%3DmTqBKMW57reZRgu9-xckyZEf0jr3miYby40h64zGGC4%26e%3D&data=05%7C01%7Csophie.hey%40comlaude.com%7Cc90ddb5da5414633734a08db240f9d57%7C442149eed2004029b9b18f029e916b85%7C0%7C0%7C638143421722366612%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=wwxAD1hohsS20FH1gOzQmenymBBHdQbRByAWs83O8yo%3D&reserved=0>) and the website Terms of Service (https://www.icann.org/privacy/tos<https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__www.icann.org_privacy_tos%26d%3DDwMFaQ%26c%3Dqmi9WrYRGQEDDOxOwKrAjW7mWovpzN_EKyRbeK_zbP0%26r%3DKepk-9GEB6JgOj0vUGl8c0hdrRM7FW-8Is-VAQU1VAm5U0rBXiZs3BfB3GfKU2uR%26m%3Do73kKku6Nol5HltVsjUZUZ4XJPUiUADbqudJrCeY5YdIxtDN07tTqDz62lao4hEG%26s%3D3UoP_EVnTFIKKRHQuGXoVMy5Eiuib0aaKk5I6uC8CVU%26e%3D&data=05%7C01%7Csophie.hey%40comlaude.com%7Cc90ddb5da5414633734a08db240f9d57%7C442149eed2004029b9b18f029e916b85%7C0%7C0%7C638143421722366612%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=L6apeXfaDi1ge%2Bnmu4V54qW%2BKcc33dX9vqzGgxtXxRY%3D&reserved=0>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.

Confidentiality Notice
This message is intended exclusively for the individual or entity to which it is addressed. This communication may contain information that is proprietary, privileged, confidential or otherwise legally exempt from disclosure. If you are not the named addressee, you are not authorized to read, print, retain, copy or disseminate this message or any part of it. If you have received this message in error, please notify the sender immediately either by phone (800-237-2000) or reply to this e-mail and delete all copies of this message.

________________________________
The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that Com Laude Group Limited (the “Com Laude Group”) does not accept any responsibility for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities. The Com Laude Group is a limited company registered in England and Wales with company number 10689074 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England. The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England and Wales with company number 6181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176 and registered office at 15 William Street, South West Lane, Edinburgh, EH3 7LL Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, a corporation incorporated in the State of Washington and principal office address at Suite 332, Securities Building, 1904 Third Ave, Seattle, WA 98101; Com Laude (Japan) Corporation, a company registered in Japan with company number 0100-01-190853 and registered office at 1-3-21 Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan; Com Laude Domain ESP S.L.U., a company registered in Spain and registered office address at Calle Barcas 2, 2, Valencia, 46002, Spain. For further information see www.comlaude.com<https://comlaude.com>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230313/b65de9ca/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.png
Type: image/png
Size: 8674 bytes
Desc: image002.png
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230313/b65de9ca/image002-0001.png>